文献速递病毒性肝炎

丙型肝炎筛查样本混合策略的真实场景验证

Real-life validation of a sample pooling strategy for screening of hepatitis C.
PubMed 文献 · Clin Microbiol Infect · 2022-09-20

在评估七种商业检测方法对混合样本中HCV-RNA的敏感性后,对2021年11月前三周连续送检的1700份样本进行抗-HCV检测并盲法混合(17池)检测HCV-RNA,混合策略检出所有标准检测阳性样本,灵敏度和特异度均为100%(CI 99.78-100%),按西班牙市场价格和人力成本可节省3320€,作者认为该策略可作为HCV大规模筛查的合适工具。

要点

  • 七种商业检测平台均能在至少10000份HCV-RNA阴性样本的混合池中检出单份丙肝病毒血症样本的HCV-RNA。
  • 1700份样本混合为17池检测,抗-HCV和HCV-RNA总体流行率均为0.24%。
  • 混合策略检出所有标准检测阳性样本,灵敏度与特异度均为100%(CI 99.78-100%)。

核心结论

  • 作者认为,混合样本策略在不损失灵敏度和特异度的情况下提高了成本效益,可作为HCV大规模筛查的合适工具。

研究设计与样本

  • 先评估七种用于测定血浆或血清HCV-RNA浓度的商业检测方法对混合样本的敏感性,再对2021年11月前三周连续送检的HCV诊断样本进行真实场景验证。
  • 样本平行且盲法混合为100份一池,共1700份样本(17池),同时检测抗-HCV和HCV-RNA。
  • 混合池结果阳性时采用解盲策略,最多需要15次HCV-RNA检测。

主要发现

  • 所有平台均能在至少10000份HCV-RNA阴性样本的混合池中检出单份丙肝病毒血症样本的HCV-RNA。
  • 1700份样本中抗-HCV和HCV-RNA的总体流行率均为0.24%。
  • 混合策略检出所有标准诊断检测(反射检测)阳性的样本,特异度和灵敏度均为100%(CI 99.78-100%)。
  • 按西班牙市场抗-HCV和HCV-RNA的中位当前价格及人力成本计算,采用混合策略可节省3320€。

临床怎么用

  • 作者认为,混合样本策略可作为HCV大规模筛查的合适工具。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To test a real-life sample pooling screening strategy which contributes to increasing the diagnostic capacity of clinical laboratories and expanding access to massive screening of hepatitis C. METHODS: After evaluating the sensitivity of the pooling strategy for seven different commercial assays which are used to determine the concentration of hepatitis C virus (HCV)-RNA in the plasma or serum, consecutive samples submitted for HCV diagnosis during the first 3 weeks of November 2021 were tested for HCV antibodies and, in parallel and in a blinded way, were pooled into 100 samples and tested for HCV-RNA. When the result was positive, a strategy to un-mask the positive(s) pool(s), which needed up to 15 total HCV-RNA tests, was used. RESULTS: All platforms were able to detect the presence of HCV-RNA in a single sample from a patient with viremic HCV present in pools of up to at least 10 000 HCV-RNA-free samples. A total of 1700 samples (17 pools) were analysed, with an overall prevalence of anti-HCV and HCV-RNA of 0.24%. After pooling, we could detect all samples previously detected using standard diagnosis tests (reflex testing) with a specificity and sensitivity of 100% (CI, 99.78-100%). Given the median current prices of anti-HCV and HCV-RNA on the market in Spain as well as personnel costs, testing using the pooling strategy would have resulted in a save of 3320€. CONCLUSIONS: Here, we demonstrated that by improving cost effectiveness, with no loss of sensitivity and specificity, the strategy of pooling samples may serve as an appropriate tool for use in large-scale screening of HCV.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Aguilera A, Fuentes A, Cea M, et al. Real-life validation of a sample pooling strategy for screening of hepatitis C. Clin Microbiol Infect. 2022. PMID: 36210627. doi:10.1016/j.cmi.2022.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。